Scripts 360 is proud to offer SPRAVATO® (esketamine) therapy, a REMS-certified, FDA-approved nasal spray treatment for adults with treatment-resistant depression (TRD) and certain cases of major depressive disorder that haven’t responded to traditional antidepressants. SPRAVATO® contains esketamine — the active form of ketamine — and works differently from standard oral antidepressants by targeting specific brain receptors linked to mood regulation. 

This innovative treatment is administered in our clinic under direct medical supervision to ensure safety and optimal results. Many patients experience rapid symptom improvement — often within hours or days — even after other therapies have failed. Because esketamine can cause sedation or dissociation, it is delivered in a controlled clinical setting with monitoring during and after each session. 

At Scripts 360, our trained clinicians will evaluate your medical history and treatment needs to determine whether SPRAVATO® is an appropriate option for you. As a certified SPRAVATO® treatment center, we are committed to providing compassionate care and cutting-edge therapy to help those with persistent depression find meaningful relief.